After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Vertex Pharmaceuticals, Inc is $110.25B. A total of 1.56 million shares were traded on the day, compared to an average of 1.52M shares.
In the most recent transaction, JEFFREY M LEIDEN bought 19,688 shares of VRTX for 434.19 per share on Nov 13 ’25. In a previous transaction on Oct 02 ’25, Biller Jonathan sold 694 shares at 404.21 per share. VRTX shares that EVP and Chief Legal Officer owns now total 15,653.
Among the insiders who bought shares, Biller Jonathan acquired of 694 shares on Oct 02 ’25 at a per-share price of $404.21. In another insider transaction, Bhatia Sangeeta N. sold 266 shares at $386.69 per share on Aug 27 ’25. Company shares held by the Director now total 4,565.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VRTX has a high of $519.68 and a low of $362.50.
As of this writing, VRTX has an earnings estimate of $5.16 per share for the current quarter. EPS was calculated based on a consensus of 23.0 estimates, with a high estimate of $5.78 per share and a lower estimate of $4.46. The company reported an EPS of $3.98 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $68.20, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.06.
